China Sky One Medical, Inc. Partners Up to Form New Stem Cell Company, Harbin Tian Xin Biological Engineering; $36.3 Million Operation
December 16, 2011 -- China Sky One Medical, together with three partners, will invest $36.3 million to create a stem cell company, which will be called Harbin Tian Xin Biological Engineering. Besides providing umbilical cord cell banking, the new company will perform the clinical applications of bone marrow stem cells, intercord mesenchymal stem cells and other human stem cells. More details....
Stock Symbol: (NSDQ: CSKI)